NO992731L - Nye substituerte tetrahydropyridinforbindelser, fremgangsmÕte ved fremstilling av dem og farmas°ytiske sammensetninger derav - Google Patents

Nye substituerte tetrahydropyridinforbindelser, fremgangsmÕte ved fremstilling av dem og farmas°ytiske sammensetninger derav

Info

Publication number
NO992731L
NO992731L NO992731A NO992731A NO992731L NO 992731 L NO992731 L NO 992731L NO 992731 A NO992731 A NO 992731A NO 992731 A NO992731 A NO 992731A NO 992731 L NO992731 L NO 992731L
Authority
NO
Norway
Prior art keywords
compounds
preparing
methods
new substituted
substituted tetrahydropyridine
Prior art date
Application number
NO992731A
Other languages
English (en)
Other versions
NO313589B1 (no
NO992731D0 (no
Inventor
Christian Marazano
Delphine Compere
C Bhupesh Das
Jean Lepagnol
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of NO992731D0 publication Critical patent/NO992731D0/no
Publication of NO992731L publication Critical patent/NO992731L/no
Publication of NO313589B1 publication Critical patent/NO313589B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO19992731A 1996-12-05 1999-06-04 Nye substituerte tetrahydropyridinforbindelser, fremgangsmåte ved fremstilling av dem og farmasöytiske sammensetninger derav NO313589B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9614951A FR2756826B1 (fr) 1996-12-05 1996-12-05 Nouveaux derives tetrahydropyridiniques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PCT/FR1997/002172 WO1998024765A1 (fr) 1996-12-05 1997-12-02 Nouveaux derives tetrahydropyridiniques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (3)

Publication Number Publication Date
NO992731D0 NO992731D0 (no) 1999-06-04
NO992731L true NO992731L (no) 1999-06-04
NO313589B1 NO313589B1 (no) 2002-10-28

Family

ID=9498371

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19992731A NO313589B1 (no) 1996-12-05 1999-06-04 Nye substituerte tetrahydropyridinforbindelser, fremgangsmåte ved fremstilling av dem og farmasöytiske sammensetninger derav

Country Status (18)

Country Link
US (1) US6232319B1 (no)
EP (1) EP0937043B1 (no)
JP (1) JP3872821B2 (no)
CN (1) CN1126739C (no)
AT (1) ATE214051T1 (no)
AU (1) AU719208B2 (no)
CA (1) CA2274133C (no)
DE (1) DE69710909T2 (no)
DK (1) DK0937043T3 (no)
ES (1) ES2172023T3 (no)
FR (1) FR2756826B1 (no)
HU (1) HUP0001773A3 (no)
NO (1) NO313589B1 (no)
NZ (1) NZ336111A (no)
PL (1) PL189372B1 (no)
PT (1) PT937043E (no)
WO (1) WO1998024765A1 (no)
ZA (1) ZA9710960B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2793245B1 (fr) * 1999-05-05 2002-10-11 Adir Nouveaux composes pyridiniques ou piperidiniques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE10164139A1 (de) 2001-12-27 2003-07-10 Bayer Ag 2-Heteroarylcarbonsäureamide
US7238715B2 (en) * 2002-12-06 2007-07-03 The Feinstein Institute For Medical Research Treatment of pancreatitis using alpha 7 receptor-binding cholinergic agonists
ATE378048T1 (de) * 2002-12-06 2007-11-15 The Feinstein Inst Medical Res Hemmung von entzündungen unter verwendungvon alpha-7-rezeptor verbindenden cholinergen agonisten
US8316104B2 (en) 2005-11-15 2012-11-20 California Institute Of Technology Method and apparatus for collaborative system
HUE026815T2 (en) 2008-11-19 2016-07-28 Forum Pharmaceuticals Inc Treatment of Cognitive Disorders with (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof
TW201031664A (en) 2009-01-26 2010-09-01 Targacept Inc Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
AU2010247835A1 (en) * 2009-05-11 2011-12-08 Envivo Pharmaceuticals, Inc. Treatment of cognitive disorders with certain alpha-7 nicotinic acid receptors in combination with acetylcholinesterase inhibitors
TWI519532B (zh) 2010-05-17 2016-02-01 艾維沃製藥公司 （Ｒ）－７－氯－Ｎ－（啶－３－基）苯並［b］噻吩－２－羧醯胺鹽酸鹽單水合物之結晶形體
RU2017136693A (ru) 2012-05-08 2019-02-08 Форум Фармасьютикалз, Инк. Способы поддержания, лечения или улучшения когнитивной функции

Also Published As

Publication number Publication date
JP2001505214A (ja) 2001-04-17
PL189372B1 (pl) 2005-07-29
ES2172023T3 (es) 2002-09-16
HK1023346A1 (en) 2000-09-08
EP0937043B1 (fr) 2002-03-06
HUP0001773A2 (hu) 2000-11-28
DE69710909T2 (de) 2002-11-07
AU7624398A (en) 1998-06-29
NO313589B1 (no) 2002-10-28
AU719208B2 (en) 2000-05-04
EP0937043A1 (fr) 1999-08-25
NO992731D0 (no) 1999-06-04
CA2274133C (fr) 2003-09-16
JP3872821B2 (ja) 2007-01-24
FR2756826B1 (fr) 1999-01-08
FR2756826A1 (fr) 1998-06-12
CN1126739C (zh) 2003-11-05
CA2274133A1 (fr) 1998-06-11
PT937043E (pt) 2002-07-31
ATE214051T1 (de) 2002-03-15
NZ336111A (en) 2000-03-27
US6232319B1 (en) 2001-05-15
CN1239951A (zh) 1999-12-29
HUP0001773A3 (en) 2002-12-28
DE69710909D1 (de) 2002-04-11
DK0937043T3 (da) 2002-06-10
WO1998024765A1 (fr) 1998-06-11
ZA9710960B (en) 1998-06-15

Similar Documents

Publication Publication Date Title
DK0562956T3 (da) Hidtil ukendte naphthylalkylaminer, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
KR900700486A (ko) 신규한 벤조피리도 피페리딘, 피페리딜리덴 및 피페라진 화합물, 조성물, 제조방법 및 이용방법
SE9904652D0 (sv) Novel Compounds
DK0871606T3 (da) Nye forbindelser og deres præparat med anti-inflammatorisk og anti-thrombotisk aktivitet
NO951162L (no) 1-(2-okso-acetyl)-piperidin-2-karboksylsyrederivater som multi-medikamentresistente sensitivisatorer for kreftceller
NO303780B1 (no) Nye 4-arylpiperaziner og 4-arylpiperidiner, sammensetning inneholdende dem samt deres anvendelse til fremstilling av terapeutikum
DK0530087T3 (da) Hidtil ukendte naphthylethylurinstof- og naphthylethylthiourinstofforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
ATE156829T1 (de) Substituierte aminophosphonatderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
NO992731D0 (no) Nye substituerte tetrahydropyridinforbindelser, fremgangsmÕte ved fremstilling av dem og farmas°ytiske sammensetninger derav
ES2153019T3 (es) Derivados de benzo-dioxano, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
DK0861250T3 (da) Amindin- og isothiourinstofderivater som inhibitorer for nitrogenmonoxidsyntase
CO4340625A1 (es) Dihidropiridinas condensadas y su utilizacion para la produccion de preparados farmaceuticos
NO20023001L (no) Substituerte piperazinderivater som MTP inhibitorer
DK0632026T3 (da) Alfa-aminosyrederivater, en fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger, der indeholder dem
ES2183492T3 (es) Nuevos derivados de nitrono,su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2153457T3 (es) Amino-alquil-benzoxazolinonas y benzotiazolinonas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
NO904135L (no) Fremgangsmaate for fremstilling av nye substituerte alkylpiperidiner og deres anvendelse som inhibitorer av kolesterolsyntese.
NO20000199L (no) Medikamenter inneholdende polyhydroksybutylpyraziner, nye polyhydroksybutylpyraziner og deres fremstilling
FR2640969B1 (no)
DK1000067T3 (da) Thiazolobenzoheterocycliske forbindelser, deres fremstilling og lægemidler indeholdende forbindelserne
ATE50248T1 (de) Ein imidazolidintrion-derivat oder ein seiner pharmazeutisch akzeptierbaren salze enthaltende pharmazeutische zusammenstellung.
ES2065855B1 (es) Procedimiento para la preparacion de nuevos derivados desoxiazafosfolipidicos con accion inhibidora de la fosfolipasa a2, nuevos derivados desoxiazafosfolipidicos obtenidos y utilizacion de los mismos.
ES2159098T3 (es) Nuevos derivados de elipticina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
DK0611755T3 (da) Hidtil ukendte (cyklohexyl)alkenforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
ATE168683T1 (de) Substituierte iminoacetonitrile mit myokardprotektiver wirkung